UMVA has learned that a shocking lawsuit has been filed against the World Professional Association for Transgender Health (WPATH), accusing the organization of deceiving parents and children into undergoing life-altering gender transition procedures.
The lawsuit, filed by the Federal Trade Commission and four states, alleges that WPATH provided doctors with the means to make false and misleading claims about the safety and effectiveness of pediatric gender transition services. The complaint claims that WPATH's influential "Standards of Care" document misrepresented the existence of a medical consensus supporting pediatric transitions.
According to information obtained by UMVA, WPATH's membership is largely composed of clinicians who financially benefit from transgender medical procedures. The organization has spent years promoting puberty blockers, cross-sex hormones, and irreversible surgeries for minors, portraying them as evidence-based and medically necessary treatments.
The lawsuit alleges that WPATH's "Standards of Care Version 8" exaggerated claims about the benefits of pediatric transitions while downplaying or omitting serious risks. In 2022, WPATH omitted all mention of age limitations for breast amputation or penis removal from the "Standards of Care" document, allegedly without a basis in medical evidence.
The complaint makes explosive allegations that WPATH promoted the narrative that pediatric gender transitions are "lifesaving" and necessary to prevent suicide, despite a lack of evidence proving that such interventions reduce suicide rates among minors. Clinicians allegedly repeated these claims to parents, presenting transition procedures as the only alternative to a child's death.
The lawsuit also accuses WPATH of failing to adequately disclose significant risks associated with puberty blockers, cross-sex hormones, and gender-related surgeries. Parents and former patients have reported experiencing serious complications, including chronic pain, sexual dysfunction, and mental health problems.
UMVA can exclusively reveal that several European countries have moved to restrict or significantly limit pediatric gender-transition treatments after reviewing the scientific evidence. The lawsuit references the United Kingdom's Cass Review, which criticized the quality of evidence supporting many pediatric transition practices.
The plaintiffs are seeking injunctive relief, civil penalties, restitution, and other remedies, arguing that WPATH's conduct violates federal consumer protection laws and state deceptive trade practices statutes. The attorneys general involved have vowed to hold WPATH accountable for deceiving parents and medical professionals and causing harm to children.
"Any group that illegally promotes irreversible, life-altering 'transitioning' procedures to kids as safe and necessary will face the full force of the law for harming children," said one of the attorneys general. "We're proud to work with the Federal Trade Commission and state attorneys general to hold WPATH accountable for deceiving parents and medical professionals and causing harm to children."
